Recombinant Anti-IgSF4 Mab
DESCRIPTION |
CATALOG # |
SIZE |
PRICE |
Recombinant Human Anti-Human IgSF4 Monoclonal Antibody |
HOM-19340 |
1mg |
Please Inquiry |
Product Detail
- Cat
- HOM-19340
- Product Overview
- Recombinant humanized antibody expressed in CHO binding to human IgSF4.
- Target
- CADM1
- Type
- Human IgG
- Species Reactivity
- Human
- Expression Host
- CHO
- Applications
- ELISA, WB, IHC, FCM, IP, IF. Optimal dilutions/concentrations should be determined by the end user.
- Clone
- Monoclonal
- Molecular Weight
- 145.41 kDa
- Purity
- >95.0% as determined by analysis by RP-HPLC & analysis by SDS-PAGE.
- Storage
- Store it under sterile conditions at -20 °C upon receiving. Recommend to pack the antibody into smaller quantities for optimal storage.
- Stability
- Samples are stable for up to twelve months from date of receipt at - °C and are stable for six months at 4 °C.
- Ship
- 2-8°C, BLUE ICE
Background
- Antigen Description
- Immunoglobulin superfamily member 4 (IGSF4) is a known ligand of CRTAM, a receptor expressed in activated NKT and CD8(+) T cells, but its function in T cell immunity has not been elucidated.
- Function
- PDZ domain binding; protein C-terminus binding; protein homodimerization activity; receptor binding; receptor binding;
- Gene ID
- 23705
- Synonyms
- CADM1; cell adhesion molecule 1; IGSF4, immunoglobulin superfamily, member 4 , TSLC1, tumor suppressor in lung cancer 1; BL2; IGSF4A; Necl 2; NECL2; nectin like 2; RA175; ST17; SYNCAM; SYNCAM1; TSLC-1; nectin-like 2; nectin-like protein 2; truncated CADM1 protein; TSLC1/Nectin-like 2/IGSF4; synaptic cell adhesion molecule; tumor suppressor in lung cancer 1; immunoglobulin superfamily member 4; immunoglobulin superfamily, member 4; spermatogenic immunoglobulin superfamily; immunoglobulin superfamily, member 4D variant 2; IGSF4; TSLC1; Necl-2; sgIGSF; sTSLC-1; synCAM1; MGC51880; MGC149785; DKFZp686F1789;
- Download Datasheet:
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Online Inquiry